FR3073147B1 - Composition d'aromatherapie - Google Patents

Composition d'aromatherapie Download PDF

Info

Publication number
FR3073147B1
FR3073147B1 FR1760435A FR1760435A FR3073147B1 FR 3073147 B1 FR3073147 B1 FR 3073147B1 FR 1760435 A FR1760435 A FR 1760435A FR 1760435 A FR1760435 A FR 1760435A FR 3073147 B1 FR3073147 B1 FR 3073147B1
Authority
FR
France
Prior art keywords
essential oils
composition
citrus
copaïba
bigaradier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1760435A
Other languages
English (en)
Other versions
FR3073147A1 (fr
Inventor
Mazis Carole Des
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR1760435A priority Critical patent/FR3073147B1/fr
Publication of FR3073147A1 publication Critical patent/FR3073147A1/fr
Application granted granted Critical
Publication of FR3073147B1 publication Critical patent/FR3073147B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une composition pour l'administration d'huiles essentielles par voie topique et/ou olfactive pour la limitation ou le traitement des symptômes liés à un choc ou à un évènement émotionnel, ou un mal-être, incluant par exemple les phénomènes d'odeurs, l'insomnie, le stress, l'angoisse, le mal-être. A cet effet, la composition selon l'invention comprend un mélange de gel silicium organique et de trois huiles essentielles, dont le Petit Grain Bigaradier (Citrus aurantium) et deux autres huiles essentielles choisies parmi le Pin Douglas (Pseudotsuga menziesii), l'Epinette Bleue (Picea pungens), le Baume de Copahu (Copaïba officinalis), l'Elemi (Canarium luzonicum), la Lime (Citrus aurantifolia) et la Maniguette Fine (Aframomum angustifolim.
FR1760435A 2017-11-07 2017-11-07 Composition d'aromatherapie Expired - Fee Related FR3073147B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1760435A FR3073147B1 (fr) 2017-11-07 2017-11-07 Composition d'aromatherapie

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1760435A FR3073147B1 (fr) 2017-11-07 2017-11-07 Composition d'aromatherapie
FR1760435 2017-11-07

Publications (2)

Publication Number Publication Date
FR3073147A1 FR3073147A1 (fr) 2019-05-10
FR3073147B1 true FR3073147B1 (fr) 2021-02-12

Family

ID=61027912

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1760435A Expired - Fee Related FR3073147B1 (fr) 2017-11-07 2017-11-07 Composition d'aromatherapie

Country Status (1)

Country Link
FR (1) FR3073147B1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0955035B1 (fr) * 1998-03-31 2004-09-29 Shiseido Company Limited Methode pour la prévention des odeurs corporelles de personnes agées
JP2005194308A (ja) * 2003-12-26 2005-07-21 Mitsubishi Chemicals Corp 徐放性香料担体及びそれを用いた徐放性香料
EP2878303B1 (fr) * 2013-11-29 2017-11-15 Doris Hefti Composition pour l'aromathérapie, la médecine aromatique et l'aromatologie
US8921303B1 (en) * 2014-01-28 2014-12-30 Avon Products, Inc. Extended release fragrance compositions

Also Published As

Publication number Publication date
FR3073147A1 (fr) 2019-05-10

Similar Documents

Publication Publication Date Title
MA30337B1 (fr) Anticorps
MA44312A (fr) Anticorps et leurs méthodes d'utilisation
MA32131B1 (fr) Antagonistes aminoalkylbiphényle n, n' disubstitués des récepteurs d2 de la prostaglandine
MA46665B1 (fr) Composés de tyrosine tyrosine de peptide cyclique couplés à un anticorps en tant que modulateurs des récepteurs du neuropeptide y
MA53937A (fr) Compositions comprenant des souches bactériennes
MA30232B1 (fr) Inhibiteurs de kinase bases sur l'hydantoine
MA32804B1 (fr) Antagonistes d'isonicotinamide des récepteurs de l'orexine
MA47392A1 (fr) Bis-octahydrophénanthrène carboxamides et leurs conjugués protéiques
MA31886B1 (fr) Anticorps anti-hepcidine et utilisations de ceux-ci
MA30041B1 (fr) Immunoglobulines
MA34474B1 (fr) Agonistes de gpr40
TN2010000230A1 (fr) Agonistes nouveaux des recepteurs de glucocorticoides
MA39219B1 (fr) Nouveaux composés inhibiteurs de la kinase lrrk2 utilisés pour le traitement du parkinson, de l’alzheimer et de la sclérose latérale amyotrophique
NO20070347L (no) Modulatorer av alfa7 nikotinske acetylkolinreseptorer og terapeutiske anvendelser
MA30876B1 (fr) Anticorps de la lymphotoxine-alpha
EA200802020A1 (ru) Тетрагидропиримидоазепины и их применение в качестве модуляторов trpv 1
MA34175B1 (fr) Anticorps anti-cxcr4 humanisés pour le traitement de cancer
MA54133B1 (fr) Composés d'aminopyrazine diol utilisés comme inhibiteurs de pi3k-y
WO2020089396A3 (fr) Compositions et procédés de traitement de maladies inflammatoires et auto-immunes
GT200900173A (es) Dispersión sólida de un antagonista de neuroquinina
MA38688B1 (fr) Composition solide pour administration orale contenant de l'acide ibandronique ou un sel pharmaceutiquement acceptable de celui-ci et de la vitamine d
MA46611A (fr) Traitements combinés comprenant des imidazopyrazinones pour le traitement de troubles psychiatriques et/ou cognitifs
MA37670A1 (fr) Anticorps anti-transglutaminase 2
MA53765A1 (fr) Tubulysines et conjugués tubulysines-protéines
MA29625B1 (fr) Immunoglobulines

Legal Events

Date Code Title Description
PLSC Publication of the preliminary search report

Effective date: 20190510

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

ST Notification of lapse

Effective date: 20230705